Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2004
11/10/2004EP1085009B1 Indan derivatives
11/10/2004EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004CN1545501A Novel cyclohexyl sulphones
11/10/2004CN1174968C 1, 2 -bis -adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/10/2004CN1174958C Purification process of keto acid
11/09/2004US6815443 5-Amino-1-pentene-3-ol substituted derivatives
11/09/2004US6815090 Organic electroluminescence device
11/09/2004CA2144344C Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
11/04/2004WO2004094363A1 Muscarinic agonists
11/04/2004WO2004094362A1 CaSR ANTAGONIST
11/04/2004WO2004069794A3 New arylpiperazinyl compounds
11/04/2004WO2004067506A3 Substituted heterocyclic compounds
11/04/2004WO2004061084A3 Modulation of protein functionalities
11/04/2004WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004WO2003077847A3 Substituted amides
11/04/2004US20040220412 Compositions and kits pertaining to analyte determination
11/04/2004US20040220237 Asthma and allergic inflammation modulators
11/04/2004US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004CA2518700A1 Muscarinic agonists
11/03/2004EP1473299A2 Isolation of nucleid acids
11/03/2004EP1472226A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
11/03/2004EP1472217A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
11/03/2004EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004EP1471912A1 Method of promoting neuronal growth
11/03/2004CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004CN1173956C Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same
11/03/2004CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/03/2004CN1173630C Plant growth regulator compositions
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004US6812229 Carbamate derivative and agricultural/horticultural fungicide
11/02/2004CA2112014C Antiallergic composition for ophthalmic or nasal use
11/02/2004CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004WO2004092100A1 Indene derivatives as pharmaceutical agents
10/28/2004WO2004091607A1 Quaternary ammonium compounds and their use as antimuscarinic agents
10/28/2004WO2004041151A3 Neuroprotective iron chelators and pharmaceutical compositions comprising them
10/28/2004WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214867 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
10/28/2004US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS
10/28/2004US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004US20040214801 9-Substituted minocycline compounds
10/28/2004US20040214043 Acenaptho(1,2-k)fluoranthene derivatives; color purity, efficient light emission, durability
10/28/2004US20040211012 For example, 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3 methyl 3-H-imidazol-1-ium chloride; prepared by reacting an aminophenol with a haloacetyl chloride, reducing product with borane-tetrahydrofuran complex, reacting compound with amine
10/28/2004US20040211011 Primary intermediates for oxidative coloration of hair
10/28/2004CA2527170A1 Therapeutic compounds
10/28/2004CA2522102A1 Quaternary ammonium compounds and their use as antimuscarinic agents
10/28/2004CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004CA2521883A1 Indene derivatives as pharmaceutical agents
10/28/2004CA2521175A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/27/2004EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004EP1470115A1 Treatment of male sexual dysfunction
10/27/2004EP1470104A2 Novel compounds that inhibit factor xa activity
10/27/2004EP1469851A1 Melanocortin receptor agonists
10/27/2004EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004CN1541210A Arylsulfonyl derivatives with 5-HT6 receptor affinity
10/27/2004CN1539833A Funcitonal molecule material containing four tertiary amine branches and preparation method
10/27/2004CN1172920C Process for producing 2-(4-alkyl-1-piperazyl)-benzaldehyde and-benzal compound
10/27/2004CN1172919C Alkyl alcohol piperazine derivativ and its application in preparing medicine for treating depression
10/27/2004CN1172911C Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/27/2004CN1172908C N-substituted benzy or phenyl aromatic amide copmound and its use
10/27/2004CN1172666C Compositions cotaining benzamide disulfide derivative for treating allergic diseases
10/26/2004US6809225 Method for producing 3,3-diarylpropylamines
10/26/2004US6809208 3-Arylbenzofuranones with electron-withdrawing substituents as stabilizers
10/26/2004US6809176 Compounds for use in treatment of cancer
10/26/2004US6809093 Drug resistance therapy
10/26/2004US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
10/26/2004CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation
10/21/2004WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors
10/21/2004WO2004089874A1 Biphenyl carboxylic amide p38 kinase inhibitors
10/21/2004WO2004089410A1 Preventive and/or remedy for neuropathic pain
10/21/2004WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties